Showing results (101-110 of 435) with videos related to

Sort By:
Pageof 44
EJNMMI Radiopharmacy and Chemistry|May 19, 2026
GMP-compliant automated synthesis and quality control of [177Lu]Lu-PSMA-I&T using the GAIA/LUNA Elysia-Raytest module for the treatment of metastatic castration-resistant prostate cancerAmélie Coussirou, Mélodie Six, Agathe Edet-Sanson, et al.
EJNMMI Radiopharmacy and Chemistry|May 20, 2026
Radiochemistry and comparative in vitro assessment of PSMA-617 labeled with lead-212 (212Pb), actinium-225 (225Ac), and lutetium-177 (177Lu)Abhijit Bera, Graham Ragland, Yuhan Zhang, et al.
EJNMMI Radiopharmacy and Chemistry|July 21, 2026
Inline gamma spectroscopy and liquid scintillation HPLC reveal daughters in 225Ac-radiopharmaceuticalGuilhem Claude, Matthias Balzer, Winfried Brenner, et al.
EJNMMI Radiopharmacy and Chemistry|April 2, 2021
The use of HEPES-buffer in the production of gallium-68 radiopharmaceuticals - time to reconsider strict pharmacopoeial limits?Jannie le Roux, Janke Kleynhans, Sietske Rubow
EJNMMI Radiopharmacy and Chemistry|August 31, 2026
The influence of functional groups and their relative position on isotopic exchange between 19F and 18F in aromatic ringsAntonia A Högnäsbacka, Miguel A Cortés González, Afrizki D Wiranegara, et al.
EJNMMI Radiopharmacy and Chemistry|October 13, 2021
On site production of [18F]PSMA-1007 using different [18F]fluoride activities: practical, technical and economical impactCostantina Maisto, Anna Morisco, Roberta de Marino, et al.
EJNMMI Radiopharmacy and Chemistry|July 19, 2022
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticalsAruna Korde, Renata Mikolajczak, Petra Kolenc, et al.
EJNMMI Radiopharmacy and Chemistry|March 24, 2021
An HPLC and UHPLC-HRMS approach to study PSMA-11 instability in aqueous solutionAntonella Iudicello, Filippo Genovese, Valentina Di Iorio, et al.
EJNMMI Radiopharmacy and Chemistry|April 18, 2024
Radiolabeled 15-mer peptide internalization is mediated by megalin (LRP2 receptor) in a CRISPR/Cas9-based LRP2 knockout human kidney cell modelAnna Durinova, Lucie Smutna, Pavel Barta, et al.
EJNMMI Radiopharmacy and Chemistry|April 11, 2025
Mitochondria-tropic radioconjugates to enhance the therapeutic potential of terbium-161Joana F Santos, Camille Van Laere, Catarina D Silva, et al.
Pageof 44